Pharmaceutical Advertising 2024 — Chapter 3: Argentina
por Ana Andrés
Áreas de práctica relacionadas: Derecho de la Salud — Life Sciences
GLOBAL LEGAL GROUP – INTERNATIONAL COMPARATIVE LEGAL GUIDES
Pharmaceutical Advertising 2024 — Chapter 3: Argentina
1 General – Medicinal Products
1.1 What laws and codes of practice govern the advertising of medicinal products in your jurisdiction?
Advertising and promotion of pharmaceutical products are subject to the regulations issued by the National Administration of Medicine, Food and Medical Devices (Administración Nacional
de Medicamentos, Alimentos y Tecnología Médica) (“ANMAT”, by its acronym in Spanish), through Disposition No 4980/2005, and by the Ministry of Health, through Resolution No 627/2007.
Law 16,463 (commonly known as the Medicines Law) provides that any form of public announcement on products that are sold under prescription is forbidden. Prescription medicines can only be promoted to healthcare professionals who are authorised to prescribe or dispense medicine and not to the general public.
The Argentine Chamber of Medical Specialities (Cámara Argentina de Especialidades Medicinales) (“CAEMe” by its acronym in Spanish) is a chamber that gathers laboratories whose members are international pharmaceutical companies located in Argentina. It has its own Code of Pharmaceutical Marketing Practices and interactions with Healthcare Professionals (“CAEMe’s Code”), and sets out rules that must be followed in relation to advertising and promotion of pharmaceutical products by its
members. CAEMe’s Code does not apply to the advertising of OTC products aimed at the general public but it does cover the advertising of such products to healthcare professionals.
Seguir leyendo:
Pharmaceutical Advertising 2024 — Chapter 3: Argentina
Ver en el sitio de ICLG.com